Free Trial

Beximco Pharmaceuticals (BXP) Competitors

GBX 38.50
0.00 (0.00%)
(As of 07/26/2024 ET)

BXP vs. PINE, MGP, ARR, SAGA, AMO, CTO, VRE, RPT, PEB, and MRS

Should you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include Pinewood Technologies Group (PINE), Medica Group (MGP), Aurora Investment Trust (ARR), Saga (SAGA), Amino Technologies (AMO), TClarke (CTO), VR Education (VRE), Enwell Energy plc (RPT.L) (RPT), Pebble Beach Systems Group (PEB), and Management Resource Solutions (MRS). These companies are all part of the "trading" industry.

Beximco Pharmaceuticals vs.

Beximco Pharmaceuticals (LON:BXP) and Pinewood Technologies Group (LON:PINE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

1.7% of Beximco Pharmaceuticals shares are held by institutional investors. Comparatively, 87.4% of Pinewood Technologies Group shares are held by institutional investors. 25.0% of Pinewood Technologies Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Pinewood Technologies Group has a net margin of 333.47% compared to Beximco Pharmaceuticals' net margin of 12.37%. Pinewood Technologies Group's return on equity of 15.86% beat Beximco Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals12.37% 10.99% 6.97%
Pinewood Technologies Group 333.47%15.86%4.17%

In the previous week, Beximco Pharmaceuticals' average media sentiment score of 0.00 equaled Pinewood Technologies Group'saverage media sentiment score.

Company Overall Sentiment
Beximco Pharmaceuticals Neutral
Pinewood Technologies Group Neutral

Beximco Pharmaceuticals has higher revenue and earnings than Pinewood Technologies Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£43.08B0.00£5.33B£0.08481.25
Pinewood Technologies Group£22.62M13.56£7.66MN/AN/A

Beximco Pharmaceuticals has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Pinewood Technologies Group has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

Beximco Pharmaceuticals received 108 more outperform votes than Pinewood Technologies Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Beximco PharmaceuticalsOutperform Votes
108
64.67%
Underperform Votes
59
35.33%
Pinewood Technologies GroupN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beximco Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Pinewood Technologies Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Beximco Pharmaceuticals and Pinewood Technologies Group tied by winning 5 of the 10 factors compared between the two stocks.

Get Beximco Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BXP vs. The Competition

MetricBeximco PharmaceuticalsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£171.75M£1.20B£5.27B£1.46B
Dividend Yield6.21%3.07%2.79%12.03%
P/E Ratio498.60438.32150.641,753.57
Price / Sales0.007,007.622,039.89313,985.13
Price / CashN/A10.1435.4233.20
Price / BookN/A6.484.942.84
Net Income£5.33B£167.87M£111.43M£168.82M
7 Day Performance-3.75%1.36%2.71%0.08%
1 Month Performance-1.28%64.94%11.35%1.46%
1 Year Performance8.45%104.95%9.83%86.85%

Beximco Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PINE
Pinewood Technologies Group
0 of 5 stars
0.00 / 5 stars
GBX 325.50
-2.4%
N/AN/A£283.58M£22.62M0.005,334
MGP
Medica Group
0 of 5 stars
0.00 / 5 stars
GBX 211
flat
N/A+0.0%£259.85M£76.98M3,516.671,212News Coverage
ARR
Aurora Investment Trust
0 of 5 stars
0.00 / 5 stars
GBX 273
-0.2%
N/A+25.6%£208.27M£56.99M390.00N/APositive News
SAGA
Saga
2.1065 of 5 stars
2.11 / 5 stars
GBX 110.80
-0.2%
GBX 154
+39.0%
-8.0%£158.84M£754.90M-136.793News Coverage
AMO
Amino Technologies
0 of 5 stars
0.00 / 5 stars
GBX 165.50
flat
N/A+0.0%£137.90M£82.70M57.07307News Coverage
CTO
TClarke
0 of 5 stars
0.00 / 5 stars
GBX 159
flat
N/A+22.3%£84.08M£491M1,135.7130
VRE
VR Education
0 of 5 stars
0.00 / 5 stars
GBX 18.45
+5.4%
N/AN/A£53.52M£1.98M-20.50220News Coverage
Gap Up
High Trading Volume
RPT
Enwell Energy plc (RPT.L)
0 of 5 stars
0.00 / 5 stars
GBX 15.33
+2.5%
N/A+0.0%£49.14M£44.30M4.03140Gap Up
PEB
Pebble Beach Systems Group
0 of 5 stars
0.00 / 5 stars
GBX 12.01
-3.9%
N/A+58.6%£14.95M£12.37M1,201.0060Gap Up
MRS
Management Resource Solutions
0 of 5 stars
0.00 / 5 stars
GBX 2.55
flat
N/A+0.0%£5.70MN/A1.3412,200

Related Companies and Tools

This page (LON:BXP) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners